Stay updated on Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page
- Check7 days agoChange DetectedAdded new help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updated the page footer metadata to include 'Last verified' and 'Revision: v3.6.0'. Old labels were removed or reformatted (Verified, Last known status was:, Intervention / Treatment), and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference2%

- Check14 days agoChange DetectedThe revision label in the page footer was updated from v3.5.4 to v3.5.5, indicating a new build of the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.5.4 appears on the page, replacing the previous Revision: v3.5.3. This indicates a platform release/update tag and does not affect the trial details shown.SummaryDifference0.1%

- Check57 days agoChange DetectedUpdated the page revision number from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.